TapewireFind a company

person · Reporting owner

Shrank William H

Disclosed activity across 3 companies

Tapewire entity
76462
SEC CIK
0001772348

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Walgreens Boots Alliance, Inc.WBA · Entity 16467DirectorAugust 13, 2025August 15, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Walgreens Boots Alliance, Inc.

Report date August 13, 2025 · Filed August 15, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Phantom Stock UnitsSEC Table II · derivative / convertible securityDirect16,820.86 Reported balance After 2025-08-13 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2025-08-13 · Grant · Acquired 16,820.86 · Balance 16,820.86

F1: The annual phantom stock grant is issued as non-employee director compensation under the Amended and Restated Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (including the applicable election forms thereunder, the "Plan") in arrears with respect to services rendered over the course of the prior year, and each unit of phantom stock is the economic equivalent of one share of the company's common stock.

F2: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan.

Filing footnotes · ownership attribution and instrument terms

F1: The annual phantom stock grant is issued as non-employee director compensation under the Amended and Restated Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (including the applicable election forms thereunder, the "Plan") in arrears with respect to services rendered over the course of the prior year, and each unit of phantom stock is the economic equivalent of one share of the company's common stock.

F2: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

HUMANA INC

Report date August 05, 2022 · Filed August 05, 2022

Section 16 reporting ended · disclosed 2022-08-05. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Humana CommonSEC Table I · non-derivativeDirect4,294 Reported balance Holding disclosure · report date 2022-08-05 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 4,294

OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $248.01 · Expires 2026-05-01Direct6,842 Reported balance Holding disclosure · report date 2022-08-05 · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · Balance 6,842

F1: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 5/1/19, vesting in three increments from 5/1/20 to 5/1/22.

OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $350.79 · Expires 2027-02-24Direct5,372 Reported balance Holding disclosure · report date 2022-08-05 · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · Balance 5,372

F2: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.

OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $376.61 · Expires 2028-02-22Direct4,057 Reported balance Holding disclosure · report date 2022-08-05 · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · Balance 4,057

F3: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.

OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $425.06 · Expires 2029-02-21Direct3,165 Reported balance Holding disclosure · report date 2022-08-05 · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · Balance 3,165

F4: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect357 Reported balance Holding disclosure · report date 2022-08-05 · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · Balance 357

F5: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F6: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect658 Reported balance Holding disclosure · report date 2022-08-05 · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · Balance 658

F5: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect873 Reported balance Holding disclosure · report date 2022-08-05 · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · Balance 873

F5: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F8: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.

Filing footnotes · ownership attribution and instrument terms

F1: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 5/1/19, vesting in three increments from 5/1/20 to 5/1/22.

F2: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.

F3: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.

F4: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25.

F5: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F6: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.

F7: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.

F8: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.

WW INTERNATIONAL, INC.

Report date June 24, 2025 · Filed June 26, 2025

Section 16 reporting ended · disclosed 2025-06-26. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect225 Ending reported balance After 2025-06-24 transaction · row 3
3 source rows · reconciled sequence

Row 1 · 2025-06-24 · Exercise / conversion · Acquired 20,795 · Balance 20,795

F1: On May 6, 2025, the Issuer and its subsidiaries (collectively, the "Debtors") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the "Chapter 11 Cases," and such court, the "Bankruptcy Court"). On June 17, 2025, the Bankruptcy Court entered an order (the "Confirmation Order") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the "Plan"). On June 24, 2025 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases.

F2: Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full.

F3: Each Deferred Stock Unit represents a right to receive one share of Old Common Stock upon settlement (as defined below).

Row 2 · 2025-06-24 · Disposition to issuer · Disposed 20,795 · Balance 0

F4: Pursuant to the Plan, on the Effective Date, all outstanding shares of the Issuer's common stock (the "Old Common Stock") were cancelled and extinguished. Pursuant to the Plan, new shares of the Issuer's common stock, no par value (the "New Common Stock") were issued to the Reporting Person on a ratio of 1 share of New Common Stock for approximately every 93 shares of Old Common Stock held by the Reporting Person on the Effective Date. The receipt of shares of New Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court.

Row 3 · 2025-06-24 · Grant · Acquired 225 · Balance 225

F4: Pursuant to the Plan, on the Effective Date, all outstanding shares of the Issuer's common stock (the "Old Common Stock") were cancelled and extinguished. Pursuant to the Plan, new shares of the Issuer's common stock, no par value (the "New Common Stock") were issued to the Reporting Person on a ratio of 1 share of New Common Stock for approximately every 93 shares of Old Common Stock held by the Reporting Person on the Effective Date. The receipt of shares of New Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court.

Deferred Stock UnitSEC Table II · derivative / convertible securityDirect0 Reported balance After 2025-06-24 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2025-06-24 · Exercise / conversion · Disposed 20,795 · Balance 0

F1: On May 6, 2025, the Issuer and its subsidiaries (collectively, the "Debtors") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the "Chapter 11 Cases," and such court, the "Bankruptcy Court"). On June 17, 2025, the Bankruptcy Court entered an order (the "Confirmation Order") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the "Plan"). On June 24, 2025 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases.

F3: Each Deferred Stock Unit represents a right to receive one share of Old Common Stock upon settlement (as defined below).

F2: Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full.

Filing footnotes · ownership attribution and instrument terms

F1: On May 6, 2025, the Issuer and its subsidiaries (collectively, the "Debtors") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the "Chapter 11 Cases," and such court, the "Bankruptcy Court"). On June 17, 2025, the Bankruptcy Court entered an order (the "Confirmation Order") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the "Plan"). On June 24, 2025 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases.

F2: Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full.

F3: Each Deferred Stock Unit represents a right to receive one share of Old Common Stock upon settlement (as defined below).

F4: Pursuant to the Plan, on the Effective Date, all outstanding shares of the Issuer's common stock (the "Old Common Stock") were cancelled and extinguished. Pursuant to the Plan, new shares of the Issuer's common stock, no par value (the "New Common Stock") were issued to the Reporting Person on a ratio of 1 share of New Common Stock for approximately every 93 shares of Old Common Stock held by the Reporting Person on the Effective Date. The receipt of shares of New Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 13, 2025 Filed Aug 15, 2025 18:01 UTC Walgreens Boots Alliance, Inc. WBA · Entity 16467 GrantPhantom Stock Units · Derivative 16,820.86 $11.89 $200,000.03
Disclosure

SEC source: 0001618921-25-000080 · wk-form4_1755295313.xml · derivative · entry 1

Shrank William H · CIK 0001772348 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,820.86

Underlying: Common Stock · 16,820.86 shares

Expires not disclosed

F1 · derivative.exercise_price: The annual phantom stock grant is issued as non-employee director compensation under the Amended and Restated Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (including the applicable election forms thereunder, the "Plan") in arrears with respect to services rendered over the course of the prior year, and each unit of phantom stock is the economic equivalent of one share of the company's common stock.

F2 · derivative.exercise_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan.

F2 · derivative.expiration_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan.

Read SEC document
June 24, 2025 Filed Jun 26, 2025 20:57 UTC WW INTERNATIONAL, INC. WW · Entity 6479 Exercise / conversionDeferred Stock Unit · Derivative 20,795 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-090485 · ownership.xml · derivative · entry 4

Shrank William H · CIK 0001772348 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,795 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On May 6, 2025, the Issuer and its subsidiaries (collectively, the "Debtors") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the "Chapter 11 Cases," and such court, the "Bankruptcy Court"). On June 17, 2025, the Bankruptcy Court entered an order (the "Confirmation Order") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the "Plan"). On June 24, 2025 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases.

F3 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of Old Common Stock upon settlement (as defined below).

F1 · kind: On May 6, 2025, the Issuer and its subsidiaries (collectively, the "Debtors") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the "Chapter 11 Cases," and such court, the "Bankruptcy Court"). On June 17, 2025, the Bankruptcy Court entered an order (the "Confirmation Order") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the "Plan"). On June 24, 2025 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases.

F2 · kind: Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full.

F1 · shares: On May 6, 2025, the Issuer and its subsidiaries (collectively, the "Debtors") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the "Chapter 11 Cases," and such court, the "Bankruptcy Court"). On June 17, 2025, the Bankruptcy Court entered an order (the "Confirmation Order") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the "Plan"). On June 24, 2025 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases.

F2 · shares: Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full.

F1 · price: On May 6, 2025, the Issuer and its subsidiaries (collectively, the "Debtors") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the "Chapter 11 Cases," and such court, the "Bankruptcy Court"). On June 17, 2025, the Bankruptcy Court entered an order (the "Confirmation Order") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the "Plan"). On June 24, 2025 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases.

F2 · price: Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full.

F2 · derivative.exercise_date: Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full.

F2 · derivative.expiration_date: Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full.

Read SEC document
June 24, 2025 Filed Jun 26, 2025 20:57 UTC WW INTERNATIONAL, INC. WW · Entity 6479 GrantCommon Stock 225 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-090485 · ownership.xml · nonDerivative · entry 3

Shrank William H · CIK 0001772348 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225

F4 · shares: Pursuant to the Plan, on the Effective Date, all outstanding shares of the Issuer's common stock (the "Old Common Stock") were cancelled and extinguished. Pursuant to the Plan, new shares of the Issuer's common stock, no par value (the "New Common Stock") were issued to the Reporting Person on a ratio of 1 share of New Common Stock for approximately every 93 shares of Old Common Stock held by the Reporting Person on the Effective Date. The receipt of shares of New Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court.

F4 · price: Pursuant to the Plan, on the Effective Date, all outstanding shares of the Issuer's common stock (the "Old Common Stock") were cancelled and extinguished. Pursuant to the Plan, new shares of the Issuer's common stock, no par value (the "New Common Stock") were issued to the Reporting Person on a ratio of 1 share of New Common Stock for approximately every 93 shares of Old Common Stock held by the Reporting Person on the Effective Date. The receipt of shares of New Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court.

Read SEC document
June 24, 2025 Filed Jun 26, 2025 20:57 UTC WW INTERNATIONAL, INC. WW · Entity 6479 Disposition to issuerCommon Stock 20,795 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-090485 · ownership.xml · nonDerivative · entry 2

Shrank William H · CIK 0001772348 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F4 · shares: Pursuant to the Plan, on the Effective Date, all outstanding shares of the Issuer's common stock (the "Old Common Stock") were cancelled and extinguished. Pursuant to the Plan, new shares of the Issuer's common stock, no par value (the "New Common Stock") were issued to the Reporting Person on a ratio of 1 share of New Common Stock for approximately every 93 shares of Old Common Stock held by the Reporting Person on the Effective Date. The receipt of shares of New Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court.

F4 · price: Pursuant to the Plan, on the Effective Date, all outstanding shares of the Issuer's common stock (the "Old Common Stock") were cancelled and extinguished. Pursuant to the Plan, new shares of the Issuer's common stock, no par value (the "New Common Stock") were issued to the Reporting Person on a ratio of 1 share of New Common Stock for approximately every 93 shares of Old Common Stock held by the Reporting Person on the Effective Date. The receipt of shares of New Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court.

Read SEC document
June 24, 2025 Filed Jun 26, 2025 20:57 UTC WW INTERNATIONAL, INC. WW · Entity 6479 Exercise / conversionCommon Stock 20,795 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-090485 · ownership.xml · nonDerivative · entry 1

Shrank William H · CIK 0001772348 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,795

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On May 6, 2025, the Issuer and its subsidiaries (collectively, the "Debtors") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the "Chapter 11 Cases," and such court, the "Bankruptcy Court"). On June 17, 2025, the Bankruptcy Court entered an order (the "Confirmation Order") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the "Plan"). On June 24, 2025 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases.

F2 · shares: Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full.

F1 · price: On May 6, 2025, the Issuer and its subsidiaries (collectively, the "Debtors") filed voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the "Chapter 11 Cases," and such court, the "Bankruptcy Court"). On June 17, 2025, the Bankruptcy Court entered an order (the "Confirmation Order") confirming the Debtors' First Amended Joint Prepackaged Plan of Reorganization, as modified by the Confirmation Order (the "Plan"). On June 24, 2025 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases.

F2 · price: Pursuant to the Plan and upon the Reporting Person ceasing to be a member of the Board of Directors, each Deferred Stock Unit settled in full.

F3 · price: Each Deferred Stock Unit represents a right to receive one share of Old Common Stock upon settlement (as defined below).

Read SEC document
December 30, 2024 Filed Jan 2, 2025 21:01 UTC WW INTERNATIONAL, INC. WW · Entity 6479 GrantDeferred Stock Unit · Derivative 3,696 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-000392 · ownership.xml · derivative · entry 1

Shrank William H · CIK 0001772348 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,795

Underlying: Common Stock · 3,696 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement.

F2 · derivative.exercise_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors.

F2 · derivative.expiration_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors.

Read SEC document
November 01, 2024 Filed Nov 5, 2024 20:59 UTC Walgreens Boots Alliance, Inc. WBA · Entity 16467 GrantCommon Stock 3,523 $0.00 $0.00
Disclosure

SEC source: 0001618921-24-000131 · wk-form4_1730858380.xml · nonDerivative · entry 1

Shrank William H · CIK 0001772348 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,523

F1 · kind: Shares issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (including the applicable election forms thereunder).

Read SEC document
September 30, 2024 Filed Oct 2, 2024 20:01 UTC WW INTERNATIONAL, INC. WW · Entity 6479 GrantDeferred Stock Unit · Derivative 3,696 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-111404 · ownership.xml · derivative · entry 1

Shrank William H · CIK 0001772348 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,099

Underlying: Common Stock · 3,696 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement.

F2 · derivative.exercise_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors.

F2 · derivative.expiration_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors.

Read SEC document
July 01, 2024 Filed Jul 3, 2024 20:42 UTC WW INTERNATIONAL, INC. WW · Entity 6479 GrantDeferred Stock Unit · Derivative 3,696 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-081585 · ownership.xml · derivative · entry 1

Shrank William H · CIK 0001772348 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,403

Underlying: Common Stock · 3,696 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement.

F2 · derivative.exercise_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors.

F2 · derivative.expiration_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 20:25 UTC WW INTERNATIONAL, INC. WW · Entity 6479 GrantDeferred Stock Unit · Derivative 3,696 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-041098 · ownership.xml · derivative · entry 1

Shrank William H · CIK 0001772348 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,707

Underlying: Common Stock · 3,696 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement.

F2 · derivative.exercise_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors.

F2 · derivative.expiration_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 21:55 UTC WW INTERNATIONAL, INC. WW · Entity 6479 GrantDeferred Stock Unit · Derivative 3,696 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-001040 · ownership.xml · derivative · entry 1

Shrank William H · CIK 0001772348 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,011

Underlying: Common Stock · 3,696 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement.

F2 · derivative.exercise_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors.

F2 · derivative.expiration_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors.

Read SEC document
October 02, 2023 Filed Oct 4, 2023 20:08 UTC WW INTERNATIONAL, INC. WW · Entity 6479 GrantDeferred Stock Unit · Derivative 2,315 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-051903 · doc4.xml · derivative · entry 1

Shrank William H · CIK 0001772348 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,315

Underlying: Common Stock · 2,315 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement.

F2 · derivative.exercise_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors.

F2 · derivative.expiration_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors.

Read SEC document
May 01, 2022 Filed May 3, 2022 17:45 UTC HUMANA INC HUM · Entity 1429 Exercise / conversionRestricted Stock Units · Derivative 504 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-011349 · form4.xml · derivative · entry 9

Shrank William H · CIK 0001772348 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 504 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F6 · derivative.exercise_date: Restricted stock units granted to reporting person on 5/1/19, 33% of the award is vesting on 5/1/20, 5/1/21, and 5/1/22.

F6 · derivative.expiration_date: Restricted stock units granted to reporting person on 5/1/19, 33% of the award is vesting on 5/1/20, 5/1/21, and 5/1/22.

Read SEC document
May 01, 2022 Filed May 3, 2022 17:45 UTC HUMANA INC HUM · Entity 1429 Tax withholdingHumana Common 164 $449.81 $73,769.58
Disclosure

SEC source: 0001062993-22-011349 · form4.xml · nonDerivative · entry 4

Shrank William H · CIK 0001772348 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,294

F11 · shares: Shares disposed of represent withholding of taxes on restricted/performance stock unit vesting.

Read SEC document
May 01, 2022 Filed May 3, 2022 17:45 UTC HUMANA INC HUM · Entity 1429 Exercise / conversionHumana Common 504 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-011349 · form4.xml · nonDerivative · entry 3

Shrank William H · CIK 0001772348 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,458

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2022 Filed May 3, 2022 17:45 UTC HUMANA INC HUM · Entity 1429 Tax withholdingHumana Common 2,250 $449.81 $1,012,082.63
Disclosure

SEC source: 0001062993-22-011349 · form4.xml · nonDerivative · entry 2

Shrank William H · CIK 0001772348 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,954

F11 · shares: Shares disposed of represent withholding of taxes on restricted/performance stock unit vesting.

Read SEC document
May 01, 2022 Filed May 3, 2022 17:45 UTC HUMANA INC HUM · Entity 1429 Exercise / conversionHumana Common 4,926 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-011349 · form4.xml · nonDerivative · entry 1

Shrank William H · CIK 0001772348 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,204

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · shares: Includes Performance Stock Units, not required to be reported until vest.

Read SEC document
February 21, 2022 Filed Feb 23, 2022 22:35 UTC HUMANA INC HUM · Entity 1429 GrantRestricted Stock Units · Derivative 873 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-005393 · form4.xml · derivative · entry 9

Shrank William H · CIK 0001772348 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 873

Underlying: Humana Common · 873 shares

Expires not disclosed

F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.

F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.

Read SEC document
February 21, 2022 Filed Feb 23, 2022 22:35 UTC HUMANA INC HUM · Entity 1429 GrantOptions · Derivative 3,165 $0.00 Strike: $425.06 $0.00
Disclosure

SEC source: 0001062993-22-005393 · form4.xml · derivative · entry 5

Shrank William H · CIK 0001772348 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,165

Underlying: Humana Common · 3,165 shares

Expires 2029-02-21

F4 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25.

F4 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25.

Read SEC document
December 15, 2021 Filed Dec 17, 2021 16:23 UTC HUMANA INC HUM · Entity 1429 Exercise / conversionRestricted Stock Units · Derivative 328 $0.00 $0.00
Disclosure

SEC source: 0001062993-21-013085 · form4.xml · derivative · entry 10

Shrank William H · CIK 0001772348 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 658

Underlying: Humana Common · 328 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.

F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.

Read SEC document
December 15, 2021 Filed Dec 17, 2021 16:23 UTC HUMANA INC HUM · Entity 1429 Exercise / conversionRestricted Stock Units · Derivative 356 $0.00 $0.00
Disclosure

SEC source: 0001062993-21-013085 · form4.xml · derivative · entry 9

Shrank William H · CIK 0001772348 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 357

Underlying: Humana Common · 356 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F6 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.

F6 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.

Read SEC document
December 15, 2021 Filed Dec 17, 2021 16:23 UTC HUMANA INC HUM · Entity 1429 Tax withholdingHumana Common 156 $459.85 $71,736.60
Disclosure

SEC source: 0001062993-21-013085 · form4.xml · nonDerivative · entry 4

Shrank William H · CIK 0001772348 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,278

Read SEC document
December 15, 2021 Filed Dec 17, 2021 16:23 UTC HUMANA INC HUM · Entity 1429 Exercise / conversionHumana Common 328 $0.00 $0.00
Disclosure

SEC source: 0001062993-21-013085 · form4.xml · nonDerivative · entry 3

Shrank William H · CIK 0001772348 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,434

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2021 Filed Dec 17, 2021 16:23 UTC HUMANA INC HUM · Entity 1429 Tax withholdingHumana Common 170 $459.85 $78,174.50
Disclosure

SEC source: 0001062993-21-013085 · form4.xml · nonDerivative · entry 2

Shrank William H · CIK 0001772348 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,106

Read SEC document
December 15, 2021 Filed Dec 17, 2021 16:23 UTC HUMANA INC HUM · Entity 1429 Exercise / conversionHumana Common 356 $0.00 $0.00
Disclosure

SEC source: 0001062993-21-013085 · form4.xml · nonDerivative · entry 1

Shrank William H · CIK 0001772348 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,276

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2021 Filed May 4, 2021 15:11 UTC HUMANA INC HUM · Entity 1429 Exercise / conversionRestricted Stock Units · Derivative 504 $0.00 $0.00
Disclosure

SEC source: 0000049071-21-000087 · edgar.xml · derivative · entry 6

Shrank William H · CIK 0001772348 · Director · Chief Med & Corp Affairs Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 504

Underlying: Humana Common · 504 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 5/1/19, 33% of the award is vesting on 5/1/20, 5/1/21, and 5/1/22.

F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 5/1/19, 33% of the award is vesting on 5/1/20, 5/1/21, and 5/1/22.

Read SEC document
May 01, 2021 Filed May 4, 2021 15:11 UTC HUMANA INC HUM · Entity 1429 Tax withholdingHumana Common 164 $446.12 $73,162.86
Disclosure

SEC source: 0000049071-21-000087 · edgar.xml · nonDerivative · entry 2

Shrank William H · CIK 0001772348 · Director · Chief Med & Corp Affairs Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 920

Read SEC document
May 01, 2021 Filed May 4, 2021 15:11 UTC HUMANA INC HUM · Entity 1429 Exercise / conversionHumana Common 504 $0.00 $0.00
Disclosure

SEC source: 0000049071-21-000087 · edgar.xml · nonDerivative · entry 1

Shrank William H · CIK 0001772348 · Director · Chief Med & Corp Affairs Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,084

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 15:43 UTC HUMANA INC HUM · Entity 1429 GrantRestricted Stock Units · Derivative 986 $0.00 $0.00
Disclosure

SEC source: 0000049071-21-000060 · edgar.xml · derivative · entry 7

Shrank William H · CIK 0001772348 · Director · Chief Med & Corp Affairs Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 986

Underlying: Humana Common · 986 shares

Expires not disclosed

F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.

F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 15:43 UTC HUMANA INC HUM · Entity 1429 GrantOptions · Derivative 4,057 $0.00 Strike: $376.61 $0.00
Disclosure

SEC source: 0000049071-21-000060 · edgar.xml · derivative · entry 4

Shrank William H · CIK 0001772348 · Director · Chief Med & Corp Affairs Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,057

Underlying: Humana Common · 4,057 shares

Expires 2028-02-22

F3 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.

F3 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.

Read SEC document
December 15, 2020 Filed Dec 17, 2020 16:49 UTC HUMANA INC HUM · Entity 1429 Exercise / conversionRestricted Stock Units · Derivative 356 $0.00 $0.00
Disclosure

SEC source: 0000049071-20-000163 · edgar.xml · derivative · entry 6

Shrank William H · CIK 0001772348 · Director · Chief Med & Corp Affairs Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 713

Underlying: Humana Common · 356 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F3 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.

F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.

Read SEC document
December 15, 2020 Filed Dec 17, 2020 16:49 UTC HUMANA INC HUM · Entity 1429 Tax withholdingHumana Common 116 $390.49 $45,296.26
Disclosure

SEC source: 0000049071-20-000163 · edgar.xml · nonDerivative · entry 2

Shrank William H · CIK 0001772348 · Director · Chief Med & Corp Affairs Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580

Read SEC document
December 15, 2020 Filed Dec 17, 2020 16:49 UTC HUMANA INC HUM · Entity 1429 Exercise / conversionHumana Common 356 $0.00 $0.00
Disclosure

SEC source: 0000049071-20-000163 · edgar.xml · nonDerivative · entry 1

Shrank William H · CIK 0001772348 · Director · Chief Med & Corp Affairs Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 696

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2020 Filed May 5, 2020 20:01 UTC HUMANA INC HUM · Entity 1429 Exercise / conversionRestricted Stock Units · Derivative 504 $0.00 $0.00
Disclosure

SEC source: 0000049071-20-000084 · edgar.xml · derivative · entry 5

Shrank William H · CIK 0001772348 · Chief Med & Corp Affairs Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,008

Underlying: Humana Common · 504 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F3 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F4 · derivative.exercise_date: Restricted stock units granted to reporting person on 5/1/19, 33% of the award is vesting on 5/1/20, 5/1/21, and 5/1/22.

F4 · derivative.expiration_date: Restricted stock units granted to reporting person on 5/1/19, 33% of the award is vesting on 5/1/20, 5/1/21, and 5/1/22.

Read SEC document
May 01, 2020 Filed May 5, 2020 20:01 UTC HUMANA INC HUM · Entity 1429 Tax withholdingHumana Common 164 $373.20 $61,205.29
Disclosure

SEC source: 0000049071-20-000084 · edgar.xml · nonDerivative · entry 2

Shrank William H · CIK 0001772348 · Chief Med & Corp Affairs Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 340

Read SEC document
May 01, 2020 Filed May 5, 2020 20:01 UTC HUMANA INC HUM · Entity 1429 Exercise / conversionHumana Common 504 $0.00 $0.00
Disclosure

SEC source: 0000049071-20-000084 · edgar.xml · nonDerivative · entry 1

Shrank William H · CIK 0001772348 · Chief Med & Corp Affairs Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 504

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 24, 2020 Filed Feb 26, 2020 22:24 UTC HUMANA INC HUM · Entity 1429 GrantRestricted Stock Units · Derivative 1,069 $0.00 $0.00
Disclosure

SEC source: 0000049071-20-000047 · edgar.xml · derivative · entry 5

Shrank William H · CIK 0001772348 · Chief Med & Corp Affairs Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,069

Underlying: Humana Common · 1,069 shares

Expires not disclosed

F3 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F3 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.

F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.

Read SEC document
February 24, 2020 Filed Feb 26, 2020 22:24 UTC HUMANA INC HUM · Entity 1429 GrantOptions · Derivative 5,372 $0.00 Strike: $350.79 $0.00
Disclosure

SEC source: 0000049071-20-000047 · edgar.xml · derivative · entry 3

Shrank William H · CIK 0001772348 · Chief Med & Corp Affairs Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,372

Underlying: Humana Common · 5,372 shares

Expires 2027-02-24

F2 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.

F2 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.

Read SEC document
May 01, 2019 Filed May 2, 2019 18:54 UTC HUMANA INC HUM · Entity 1429 GrantRestricted Stock Units · Derivative 1,512 $0.00 $0.00
Disclosure

SEC source: 0000049071-19-000062 · edgar.xml · derivative · entry 3

Shrank William H · CIK 0001772348 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,512

Underlying: Humana Common · 1,512 shares

Expires not disclosed

F2 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F2 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F3 · derivative.exercise_date: Restricted stock units granted to reporting person on 5/1/19, 33% of the award is vesting on 5/1/20, 5/1/21, and 5/1/22.

F3 · derivative.expiration_date: Restricted stock units granted to reporting person on 5/1/19, 33% of the award is vesting on 5/1/20, 5/1/21, and 5/1/22.

Read SEC document
May 01, 2019 Filed May 2, 2019 18:54 UTC HUMANA INC HUM · Entity 1429 GrantOptions · Derivative 6,842 $0.00 Strike: $248.01 $0.00
Disclosure

SEC source: 0000049071-19-000062 · edgar.xml · derivative · entry 2

Shrank William H · CIK 0001772348 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,842

Underlying: Humana Common · 6,842 shares

Expires 2026-05-01

F1 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 5/1/19, vesting in three increments from 5/1/20 to 5/1/22.

F1 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 5/1/19, vesting in three increments from 5/1/20 to 5/1/22.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.